Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
6.35
-0.17 (-2.61%)
At close: Jun 2, 2026, 4:00 PM EDT
6.34
-0.01 (-0.16%)
Pre-market: Jun 3, 2026, 4:14 AM EDT
Absci Revenue
Absci had revenue of $215.00K in the quarter ending March 31, 2026, a decrease of -81.76%. This brings the company's revenue in the last twelve months to $1.84M, down -61.87% year-over-year. In the year 2025, Absci had annual revenue of $2.80M, down -38.24%.
Revenue (ttm)
$1.84M
Revenue Growth
-61.87%
P/S Ratio
539.21
Revenue / Employee
$13,114
Employees
140
Market Cap
990.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.80M | -1.73M | -38.24% |
| Dec 31, 2024 | 4.53M | -1.18M | -20.71% |
| Dec 31, 2023 | 5.72M | -29.00K | -0.50% |
| Dec 31, 2022 | 5.75M | 965.00K | 20.18% |
| Dec 31, 2021 | 4.78M | 2.00K | 0.04% |
| Dec 31, 2020 | 4.78M | 2.72M | 132.04% |
| Dec 31, 2019 | 2.06M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MannKind | 360.78M |
| ARS Pharmaceuticals | 98.99M |
| Aktis Oncology | 8.28M |
| Inventiva | 7.94M |
| EyePoint | 7.61M |
| DBV Technologies | 5.74M |
ABSI News
- 5 days ago - Absci initiated with a Buy at BTIG - TheFly
- 13 days ago - Absci to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 19 days ago - Absci price target lowered to $4.10 from $4.20 at Morgan Stanley - TheFly
- 21 days ago - Absci price target raised to $11 from $9 at JonesResearch - TheFly
- 26 days ago - Absci reports Q1 EPS (19c), consensus (20c) - TheFly
- 26 days ago - Absci Earnings Call Transcript: Q1 2026 - Transcripts
- 26 days ago - Absci Earnings release: Q1 2026 - Filings
- 26 days ago - Absci Quarterly report: Q1 2026 - Filings